Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06757192 · ClinicalTrials.gov registry record

CRC Screening in Unscreened Individuals 45-54

A clinical trial of Colorectal Cancer Screening, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06757192 is a study of Colorectal Cancer Screening that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 5,881-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06757192, a study of Colorectal Cancer Screening, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to understand the barriers and facilitators to completing colorectal cancer screening from the patient and community health center staff perspective. The main question it aims to answer is to identify system-level determinants of colorectal cancer screening in individuals aged 45 to 54. Participants will be asked to partake in one-time interviews either online or in-person and community health center staff will also be asked to take an online survey.

Study Locations (1)

Massachusetts

  • Codman Square Health Center - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-16
Est. Completion 2029-08-31

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06757192

The ClinicalTrials.gov registry entry for NCT06757192 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,881-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 0 interventions.

NCT06757192 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06757192 about?

NCT06757192 is a clinical study titled "CRC Screening in Unscreened Individuals 45-54". The goal of this observational study is to understand the barriers and facilitators to completing colorectal cancer screening from the patient and community health center staff perspective. The main question it aims to answer is to identify system-level determinants of colorectal cancer screening in...

What is the current status of trial NCT06757192?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-06-16. Estimated completion is 2029-08-31.

What conditions does trial NCT06757192 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening.

Who is sponsoring clinical trial NCT06757192?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06757192 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.